| Page 1259 | Kisaco Research
 

Pedro Correa de Sampaio

CEO
Neobe Therapeutics

Pedro Correa de Sampaio

CEO
Neobe Therapeutics

Pedro Correa de Sampaio

CEO
Neobe Therapeutics
 

Olivier Negre

CSO
Smart Immune

Olivier Negre

CSO
Smart Immune

Olivier Negre

CSO
Smart Immune
 

Mikhail Steklov

Team Lead, Cell Fitness Group
T-Knife Therapeutics

Mikhail Steklov

Team Lead, Cell Fitness Group
T-Knife Therapeutics

Mikhail Steklov

Team Lead, Cell Fitness Group
T-Knife Therapeutics
 

Michael Traxlmayr

Senior Scientist
BOKU

Michael Traxlmayr

Senior Scientist
BOKU

Michael Traxlmayr

Senior Scientist
BOKU
 

Marvin Gee

VP, Target Discovery & Co-founder
3T Biosciences

Marvin Gee

VP, Target Discovery & Co-founder
3T Biosciences

Marvin Gee

VP, Target Discovery & Co-founder
3T Biosciences
 

Magdalena Krol

Co-founder & Member of the Board
Cellis

Magdalena Krol

Co-founder & Member of the Board
Cellis

Magdalena Krol

Co-founder & Member of the Board
Cellis
 

Luca Gattinoni

Director, Division of Functional Immune Cell Modulation
Leibniz Institute for Immunotherapy

Luca Gattinoni

Director, Division of Functional Immune Cell Modulation
Leibniz Institute for Immunotherapy

Luca Gattinoni

Director, Division of Functional Immune Cell Modulation
Leibniz Institute for Immunotherapy
 

Juliana Dias Alves Pinto

Head of GMP CAR-T Production
Centre for Cell Gene & Tissue Therapeutics (CCGTT)

Juliana Dias Alves Pinto

Head of GMP CAR-T Production
Centre for Cell Gene & Tissue Therapeutics (CCGTT)

Juliana Dias Alves Pinto

Head of GMP CAR-T Production
Centre for Cell Gene & Tissue Therapeutics (CCGTT)
 

Joël Plumas

Co-founder & CSO
PDC*Line Pharma

Joël Plumas

Co-founder & CSO
PDC*Line Pharma

Joël Plumas

Co-founder & CSO
PDC*Line Pharma
 

Joachim Koch

VP, Translational Immunobiology
Affimed

Joachim Koch

VP, Translational Immunobiology
Affimed

Joachim Koch

VP, Translational Immunobiology
Affimed